stars 1 stars 2 stars 3

Small-molecule drug discovery is being compared to searching for a needle in a haystack. At CrystalsFirst, we have built a better way: using a “magnet” to attract the best-suited molecules. MAGNET Discovery Engine accelerates small molecule drug discovery by uniting patented high-throughput structural biology with AI-powered design. This integration of vertically scaling proprietary “labware” with horizontally scaling of AI-driven design tools offers the industry to systematically uncover, validate, and optimize ligands with a speed and confidence that was previously out of reach. With a track record of over 60 structurally-enabled drug targets, the MAGNET has been applied successfully across: target-to-hit discovery, hit-to-lead development, lead optimization.

CrystalsFirst Questions

The CrystalsFirst annual revenue was $3 million in 2026.

Serghei Glinca is the Founder and CEO of CrystalsFirst.

14 people are employed at CrystalsFirst.

CrystalsFirst is based in Hamburg, Hamburg.

The NAICS codes for CrystalsFirst are [54, 541].

The SIC codes for CrystalsFirst are [873, 87].

Top CrystalsFirst Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users